ArticleScientific reports2026
Sustainable improvement of single cross maize performance using vinasse-based biofertilizer.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sustainable maize (Zea mays L.) production can be enhanced through effective biofertilization practices, such as the application of vinasse, which improves plant growth and yield traits. This study aimed to evaluate the effect of vinasse as an organic biofertilizer on the growth, yield, and quality of three maize single crosses, and to assess genotype-trait relationships using GGE biplot analysis for sustainable single-cross selection. A two-year field experiment was conducted during the 2022 and 2023 seasons at the Agronomy Experimental Farm, Faculty of Agriculture, Assiut University, Egypt. The experiment was arranged in a strip-plot design within a randomized complete block design (RCBD) with three replications. Treatments included four vinasse solution levels (0, 1, 2, and 3 L plot
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.